Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BL, ? 3.3mm NC, SLActive 12mm, TiZr, NTP: medical device reports filed with FDA

4,459 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

4,459
device reports naming the brand
0% of all MAUDE reports · about 653 a year
472
reports, 12 months to August 2026
606 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

4,459 medical device reports received by FDA name the brand "BL, ? 3.3mm NC, SLActive 12mm, TiZr, NTP" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from September 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

472 reports arrived in the 12 months to August 2026, down 22% from 606 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (67.2%), loss of osseointegration (20.7%) and fracture (4%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

075150Sep 2021: 45Oct 2021: 60Nov 2021: 53Dec 2021: 472022Jan 2022: 65Feb 2022: 35Mar 2022: 42Apr 2022: 52May 2022: 49Jun 2022: 35Jul 2022: 65Aug 2022: 50Sep 2022: 60Oct 2022: 49Nov 2022: 41Dec 2022: 752023Jan 2023: 33Feb 2023: 54Mar 2023: 48Apr 2023: 41May 2023: 81Jun 2023: 72Jul 2023: 61Aug 2023: 53Sep 2023: 46Oct 2023: 74Nov 2023: 46Dec 2023: 752024Jan 2024: 45Feb 2024: 48Mar 2024: 49Apr 2024: 61May 2024: 47Jun 2024: 24Jul 2024: 53Aug 2024: 54Sep 2024: 56Oct 2024: 63Nov 2024: 57Dec 2024: 442025Jan 2025: 48Feb 2025: 33Mar 2025: 32Apr 2025: 22May 2025: 0Jun 2025: 150Jul 2025: 49Aug 2025: 52Sep 2025: 41Oct 2025: 44Nov 2025: 29Dec 2025: 532026Jan 2026: 44Feb 2026: 25Mar 2026: 50Apr 2026: 36May 2026: 47Jun 2026: 32Jul 2026: 29Aug 2026: 42

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

03426842019: 56520192020: 53120202021: 60220212022: 61820222023: 68420232024: 60120242025: 55320252026: 3052026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%4,459
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report85.2%3,797
Voluntary report0%0
User facility report0%0
Distributor report14.8%662
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate2,99567.2%62.8%
Loss of osseointegration92420.7%22.4%
Fracturea broken bone1794%1.6%
Difficult to insertthe device was hard to insert521.2%0.4%
Separation failure120.3%0.1%
Unintended movement40.1%0%
Therapeutic or diagnostic output failure30.1%0%
Unstable30.1%0%
Activation, positioning or separation problem20%0%
Defective devicethe device was defective10%0%
Difficult to removethe device was hard to remove10%0%
Output problem10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis1,11425%
Painpain, site not specified76317.1%
Tissue damage70115.7%
Inflammationinflammation3998.9%
Swelling/ edema2846.4%
Hemorrhage/blood loss/bleeding2676%
Fistula2024.5%
Abscessa collection of pus1403.1%
Hyperresponsive to stimuli1012.3%
Failure of implant641.4%
Swellingswelling431%
Hypersensitivity/allergic reaction240.5%
Increased sensitivity200.4%
Inadequate osseointegration160.4%
Numbnessnumbness100.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBL, ? 3.3mm NC, SLActive 12mm, TiZr, NTPProduct code DZEAll MAUDE reports
Reports4,4593,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer85.2%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BL, ? 3.3mm NC, SLActive 12mm, TiZr, NTP reports

How many FDA reports name BL, ? 3.3mm NC, SLActive 12mm, TiZr, NTP?

4,459 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 472 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (67.2%), loss of osseointegration (20.7%), fracture (4%), difficult to insert (1.2%) and separation failure (0.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (85.2%) and distributor reports (14.8%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BL, ? 3.3mm NC, SLActive 12mm, TiZr, NTP was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.